Literature DB >> 21841101

Does family medicine have a professional obligation to play a leading role in pharmaceutical industry-sponsored drug research?: no.

Joel Lexchin1.   

Abstract

Mesh：

Year:  2011        PMID： 21841101      PMCID： PMC3155430     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  11 in total

1.  Relation between agendas of the research community and the research consumer.

Authors:  D Tallon; J Chard; P Dieppe
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

2.  Financial anatomy of biomedical research.

Authors:  Hamilton Moses; E Ray Dorsey; David H M Matheson; Samuel O Thier
Journal:  JAMA       Date:  2005-09-21       Impact factor: 56.272

3.  Clinical trial investigators and their prescribing patterns: another dimension to the relationship between physician investigators and the pharmaceutical industry.

Authors:  Bruce M Psaty; Drummond Rennie
Journal:  JAMA       Date:  2006-06-21       Impact factor: 56.272

Review 4.  Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Authors:  Stephan Heres; John Davis; Katja Maino; Elisabeth Jetzinger; Werner Kissling; Stefan Leucht
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

Review 5.  Pharmaceutical company funding and its consequences: a qualitative systematic review.

Authors:  Sergio Sismondo
Journal:  Contemp Clin Trials       Date:  2007-08-16       Impact factor: 2.226

6.  Participation of life-science faculty in research relationships with industry.

Authors:  D Blumenthal; E G Campbell; N Causino; K S Louis
Journal:  N Engl J Med       Date:  1996-12-05       Impact factor: 91.245

7.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

Review 8.  The ADVANTAGE seeding trial: a review of internal documents.

Authors:  Kevin P Hill; Joseph S Ross; David S Egilman; Harlan M Krumholz
Journal:  Ann Intern Med       Date:  2008-08-19       Impact factor: 25.391

9.  Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.

Authors:  Jeffrey R Lisse; Monica Perlman; Gunnar Johansson; James R Shoemaker; Joy Schechtman; Carol S Skalky; Mary E Dixon; Adam B Polis; Arthur J Mollen; Gregory P Geba
Journal:  Ann Intern Med       Date:  2003-10-07       Impact factor: 25.391

10.  Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.

Authors:  Lisa Bero; Fieke Oostvogel; Peter Bacchetti; Kirby Lee
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.